Camber Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-600,000
| Closed | -$43.7M | – | 28 |
|
|
2018
Q4 | $43.7M | Buy |
+600,000
| New | +$43.7M | 2.08% | 18 |
|
|
2015
Q4 | – | Sell |
-250,000
| Closed | -$20.1M | – | 42 |
|
|
2015
Q3 | $20.1M | Buy |
+250,000
| New | +$20.1M | 1.72% | 19 |
|
|
2013
Q3 | – | Sell |
-1,000,000
| Closed | -$31M | – | 33 |
|
|
2013
Q2 | $31M | Buy |
+1,000,000
| New | +$31M | 3.19% | 11 |
|